BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20803552)

  • 1. Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
    Ridgway LD; Wetzel MD; Marchetti D
    J Cell Biochem; 2010 Dec; 111(5):1299-309. PubMed ID: 20803552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas.
    Pan YR; Chen CC; Chan YT; Wang HJ; Chien FT; Chen YL; Liu JL; Yang MH
    Nat Commun; 2018 Sep; 9(1):3696. PubMed ID: 30209389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.
    Chen X; Shao Y; Wei W; Zhu S; Li Y; Chen Y; Li H; Tian H; Sun G; Niu Y; Shang Z
    Cell Death Dis; 2022 Nov; 13(11):927. PubMed ID: 36335093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Imputation for Single-Cell RNA-seq.
    Gan L; Vinci G; Allen GI
    J Comput Biol; 2022 May; 29(5):465-482. PubMed ID: 35325552
    [No Abstract]   [Full Text] [Related]  

  • 5. High ARHGEF2 (GEF-H1) Expression is Associated with Poor Prognosis Via Cell Cycle Regulation in Patients with Pancreatic Cancer.
    Nakao Y; Nakagawa S; Yamashita YI; Umezaki N; Okamoto Y; Ogata Y; Yasuda-Yoshihara N; Itoyama R; Yusa T; Yamashita K; Miyata T; Okabe H; Hayashi H; Imai K; Baba H
    Ann Surg Oncol; 2021 Aug; 28(8):4733-4743. PubMed ID: 33393038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and functions of the RhoA regulatory guanine nucleotide exchange factor GEF-H1.
    Joo E; Olson MF
    Small GTPases; 2021; 12(5-6):358-371. PubMed ID: 33126816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho GTPases in the Amygdala-A Switch for Fears?
    Sarowar T; Grabrucker AM
    Cells; 2020 Aug; 9(9):. PubMed ID: 32858950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.
    Hubka KM; Carson DD; Harrington DA; Farach-Carson MC
    Acta Biomater; 2019 Oct; 97():385-398. PubMed ID: 31351252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4.
    Ochieng J; Nangami G; Sakwe A; Rana T; Ingram S; Goodwin JS; Moye C; Lammers P; Adunyah SE
    FEBS Lett; 2018 Oct; 592(19):3274-3285. PubMed ID: 30179249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the C-domain of heparanase during AGE-induced macrophage inflammatory response.
    Qin Q; Xu G; Qi W; Guo M; Wang Z; Xu W; Qiao Z; Gu Y; Niu J
    Exp Ther Med; 2017 Aug; 14(2):1017-1022. PubMed ID: 28810553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity.
    Schillaci O; Fontana S; Monteleone F; Taverna S; Di Bella MA; Di Vizio D; Alessandro R
    Sci Rep; 2017 Jul; 7(1):4711. PubMed ID: 28680152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review.
    Ghidini M; Petrelli F; Hahne JC; De Giorgi A; Toppo L; Pizzo C; Ratti M; Barni S; Passalacqua R; Tomasello G
    Med Oncol; 2017 Apr; 34(4):62. PubMed ID: 28315230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embracing rejection: Immunologic trends in brain metastasis.
    Farber SH; Tsvankin V; Narloch JL; Kim GJ; Salama AK; Vlahovic G; Blackwell KL; Kirkpatrick JP; Fecci PE
    Oncoimmunology; 2016 Jul; 5(7):e1172153. PubMed ID: 27622023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanine nucleotide exchange factor H1 can be a new biomarker of melanoma.
    Shi J; Guo B; Zhang Y; Hui Q; Chang P; Tao K
    Biologics; 2016; 10():89-98. PubMed ID: 27462139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding melanoma metastasis.
    Damsky WE; Rosenbaum LE; Bosenberg M
    Cancers (Basel); 2010 Dec; 3(1):126-63. PubMed ID: 24212610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma brain metastases: an unmet challenge in the era of active therapy.
    Gorantla V; Kirkwood JM; Tawbi HA
    Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases from colorectal cancer: microenvironment and molecular mechanisms.
    Zang YW; Gu XD; Xiang JB; Chen ZY
    Int J Mol Sci; 2012 Nov; 13(12):15784-800. PubMed ID: 23443093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the blood-brain barrier in the formation of brain metastases.
    Wilhelm I; Molnár J; Fazakas C; Haskó J; Krizbai IA
    Int J Mol Sci; 2013 Jan; 14(1):1383-411. PubMed ID: 23344048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of cortical myosin phosphorylation by p114RhoGEF drives cell migration and tumor cell invasion.
    Terry SJ; Elbediwy A; Zihni C; Harris AR; Bailly M; Charras GT; Balda MS; Matter K
    PLoS One; 2012; 7(11):e50188. PubMed ID: 23185572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
    Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
    Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.